Did generic drug makers act as a 'private sector cartel?'

Affordable health care is a persistent concern for Americans and a topic of great political debate. Typically, generic prescription drugs offer a cheaper alternative to name brands, but a new multi-state lawsuit alleges that their manufacturers have been artificially raising prices. John Yang talks to William Tong, attorney general of Connecticut, whose office has been leading the investigation.